Latest filings (excl ownership)
15-15D
Suspension of duty to report
1 Aug 17
EFFECT
Notice of effectiveness
27 Jul 17
8-K
Completion of Acquisition or Disposition of Assets
25 Jul 17
POS AM
Prospectus update (post-effective amendment)
25 Jul 17
SC 14D9/A
Tender offer solicitation (amended)
25 Jul 17
SC TO-T/A
Third party tender offer statement (amended)
25 Jul 17
SC TO-T/A
Third party tender offer statement (amended)
10 Jul 17
UPLOAD
Letter from SEC
3 Jul 17
8-K
Entry into a Material Definitive Agreement
26 Jun 17
SC 14D9
Tender offer solicitation
26 Jun 17
SC TO-C
Information about tender offer
26 Jun 17
SC TO-C
Information about tender offer
26 Jun 17
SC TO-T
Third party tender offer statement
26 Jun 17
8-K
Entry into a Material Definitive Agreement
22 Jun 17
SC TO-C
Information about tender offer
14 Jun 17
SC TO-C
Information about tender offer
13 Jun 17
8-K
Tender and Support Agreement
12 Jun 17
SC TO-C
Information about tender offer
12 Jun 17
SC TO-C
Information about tender offer
12 Jun 17
SC14D9C
Written communication relating to third party tender offer
12 Jun 17
10-Q
2017 Q1
Quarterly report
16 May 17
8-K
Miramar Labs, Inc. ® Reports
15 May 17
NT 10-Q
Notice of late quarterly filing
15 May 17
10-K/A
2016 FY
Annual report (amended)
28 Apr 17
10-K
2016 FY
Annual report
17 Mar 17
8-K
Miramar Labs, Inc.® Reports Fourth Quarter and Full Year
17 Mar 17
D
$3M in debt / options, sold $2.46M, 3 investors
9 Feb 17
424B3
Prospectus supplement
3 Feb 17
8-K
Entry into a Material Definitive Agreement
2 Feb 17
EFFECT
Notice of effectiveness
1 Feb 17
S-1/A
IPO registration (amended)
30 Jan 17
S-1/A
IPO registration (amended)
9 Jan 17
UPLOAD
Letter from SEC
14 Dec 16
CORRESP
Correspondence with SEC
23 Nov 16
S-1/A
IPO registration (amended)
23 Nov 16
UPLOAD
Letter from SEC
10 Nov 16
10-Q
2016 Q3
Quarterly report
9 Nov 16
8-K
Miramar Labs, Inc. ® Reports Record Third Quarter
8 Nov 16
S-1
IPO registration
14 Oct 16
CT ORDER
Confidential treatment order
15 Sep 16
Latest ownership filings
No filings